Bjarne Bogen
#120,609
Most Influential Person Now
Norwegian physician, immunologist, inventor and professor
Bjarne Bogen's AcademicInfluence.com Rankings
Bjarne Bogenbiology Degrees
Biology
#8971
World Rank
#12119
Historical Rank
Immunology
#672
World Rank
#694
Historical Rank
Bjarne Bogenphilosophy Degrees
Philosophy
#10582
World Rank
#14514
Historical Rank
Logic
#7440
World Rank
#9201
Historical Rank
Download Badge
Biology Philosophy
Why Is Bjarne Bogen Influential?
(Suggest an Edit or Addition)According to Wikipedia, Bjarne Bogen is a Norwegian immunologist, inventor and physician. He is widely known for his research on DNA vaccines, autoimmune disorders and cancer immunology. Career Bogen graduated with a medical degree from the University of Oslo in 1977. In the following two years, he completed his internship at Sandnessjøen hospital and in the municipalities of Lurøy and Træna at the coastline of northern Norway. In 1984, at the University of Tromsø he defended his PhD thesis entitled "Murine Th and B Lymphocyte Recognition of Isologous Immunoglobulin".
Bjarne Bogen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species (2016) (582)
- Endocytic pathways regulate Toll‐like receptor 4 signaling and link innate and adaptive immunity (2006) (474)
- The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors (1999) (456)
- Primary antitumor immune response mediated by CD4+ T cells. (2005) (430)
- MHC class II—Restricted presentation of intracellular antigen (1991) (265)
- Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer (2011) (264)
- B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. (1989) (231)
- Cutting Edge: Expression of XCR1 Defines Mouse Lymphoid-Tissue Resident and Migratory Dendritic Cells of the CD8α+ Type (2011) (192)
- Idiotope‐specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules (1986) (178)
- Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma (1996) (168)
- How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules? (2014) (166)
- Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors. (1994) (151)
- Broad and Largely Concordant Molecular Changes Characterize Tolerogenic and Immunogenic Dendritic Cell Maturation in Thymus and Periphery. (2016) (120)
- Human XCR1+ Dendritic Cells Derived In Vitro from CD34+ Progenitors Closely Resemble Blood Dendritic Cells, Including Their Adjuvant Responsiveness, Contrary to Monocyte-Derived Dendritic Cells (2014) (103)
- Clonal deletion of specific thymocytes by an immunoglobulin idiotype. (1993) (102)
- Vaccine molecules targeting Xcr1 on cross‐presenting DCs induce protective CD8+ T‐cell responses against influenza virus (2015) (94)
- The role of idiotype-specific, CD4+ T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells. (1993) (91)
- Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells. (2013) (90)
- Naive CD4+ T cells confer idiotype‐specific tumor resistance in the absence of antibodies (1995) (88)
- Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells. (2000) (85)
- Cutting Edge: Link Between Innate and Adaptive Immunity: Toll-Like Receptor 2 Internalizes Antigen for Presentation to CD4+ T Cells and Could Be an Efficient Vaccine Target1 (2003) (82)
- Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule. (1989) (78)
- Liver Metastasis of Cancer Facilitated by Chemokine Receptor CCR6 (2003) (76)
- Clonal deletion of thymocytes as a tumor escape mechanism (1998) (75)
- Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma. (2015) (73)
- Processing and presentation of idiotypes to MHC-restricted T cells. (1993) (73)
- Weak positive selection of transgenic T cell receptor‐bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities (1992) (73)
- Laser-Assisted Intradermal Delivery of Adjuvant-Free Vaccines Targeting XCR1+ Dendritic Cells Induces Potent Antitumoral Responses (2015) (72)
- Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells (2015) (68)
- DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells. (2006) (68)
- The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma (2013) (67)
- Dual T cell receptor T cells have a decreased sensitivity to physiological ligands due to reduced density of each T cell receptor (1996) (66)
- Delivery of Antigen to CD40 Induces Protective Immune Responses against Tumors1 (2007) (65)
- Monoclonal antibodies produced by muscle after plasmid injection and electroporation. (2004) (65)
- A model for cancer-suppressive inflammation (2012) (64)
- A Novel Mouse Model for Multiple Myeloma (MOPC315.BM) That Allows Noninvasive Spatiotemporal Detection of Osteolytic Disease (2012) (59)
- Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells (1999) (59)
- Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an In Situ Inflammatory Immune Response. (2016) (58)
- Synthetic peptides and β‐chain gene rearrangements reveal a diversified T cell repertoire for a λ light chain third hypervariable region (1986) (57)
- Resting small B cells present endogenous immunoglobulin variable‐region determinants to idiotope‐specific CD4+ T cells in vivo (1999) (55)
- A mouse C kappa-specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation. (2002) (55)
- Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences. (2007) (55)
- IL-10 mediates plasmacytosis-associated immunodeficiency by inhibiting complement-mediated neutrophil migration. (2016) (55)
- T helper cell recognition of idiotopes on λ2 light chains of M315 and T952: evidence for dependence on somatic mutations in the third hypervariable region (1985) (51)
- Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells. (2009) (50)
- Lymphomas can develop from B cells chronically helped by idiotype-specific T cells (2007) (50)
- Systemic Autoimmune Disease Caused by Autoreactive B Cells That Receive Chronic Help from Ig V Region-Specific T Cells1 (2005) (49)
- Thymic skewing of the CD4/CD8 ratio maps with the T-cell receptor α-chain locus (1998) (49)
- DNA Vaccine that Targets Hemagglutinin to MHC Class II Molecules Rapidly Induces Antibody-Mediated Protection against Influenza (2013) (48)
- Efficient Delivery of T Cell Epitopes to APC by Use of MHC Class II-Specific Troybodies1 (2002) (46)
- Polarizing T and B Cell Responses by APC-Targeted Subunit Vaccines (2015) (44)
- A stimulatory monoclonal antibody detecting T cell receptor diversity among idiotype‐specific, major histocompatibility complex‐restricted T cell clones (1990) (43)
- Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice. (2012) (43)
- Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies. (2003) (43)
- CD4+ T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models (2019) (42)
- MHC-Restricted Ig V Region-Driven T-B Lymphocyte Collaboration: B Cell Receptor Ligation Facilitates Switch to IgG Production (2004) (42)
- Tumor Killing by CD4+ T Cells Is Mediated via Induction of Inducible Nitric Oxide Synthase-Dependent Macrophage Cytotoxicity (2018) (41)
- Expanding the Versatility of Phage Display II: Improved Affinity Selection of Folded Domains on Protein VII and IX of the Filamentous Phage (2011) (41)
- Anti‐Tumour Activity of Idiotype‐Specific, MHC‐Restricted Th1 and Th2 Clones In Vitro and In Vivo (1993) (40)
- TLR3–Responsive, XCR1+, CD141(BDCA-3)+/CD8α+-Equivalent Dendritic Cells Uncovered in Healthy and Simian Immunodeficiency Virus–Infected Rhesus Macaques (2014) (40)
- Chronic Lymphocytic Leukemia Cells Express CD38 in Response to Th1 Cell–Derived IFN-γ by a T-bet–Dependent Mechanism (2015) (39)
- Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer (2019) (39)
- Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model (2014) (39)
- The Specificity of Targeted Vaccines for APC Surface Molecules Influences the Immune Response Phenotype (2013) (38)
- Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model (2011) (38)
- T cell recognition of the dominant I-A(k)-restricted hen egg lysozyme epitope: critical role for asparagine deamidation. (2001) (38)
- The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: Implications for peptide vaccination (2001) (36)
- CD4+ T-cell-Mediated Rejection of MHC Class II-Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs. (2018) (36)
- Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis (2004) (36)
- Restricted α/β receptor gene usage of idiotype‐specific major histocompatibility complex‐restricted T cells: Selection for CDR3‐related sequences (1992) (35)
- Targeting Influenza Virus Hemagglutinin to Xcr1+ Dendritic Cells in the Absence of Receptor-Mediated Endocytosis Enhances Protective Antibody Responses (2017) (35)
- Immunoglobulin as a vehicle for foreign antigenic peptides immunogenic to T cells. (1997) (33)
- Ca2+ mobilization in physiologically stimulated single T cells gradually increases with peptide concentration (analog signaling) (1994) (33)
- T helper cells recognize an idiotope located on peptide 88-114/117 of the light chain variable domain of an isologous myeloma protein (315) (1983) (33)
- Targeting Conventional Dendritic Cells to Fine-Tune Antibody Responses (2019) (32)
- Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination (2016) (32)
- Peptide phage libraries can be an efficient tool for identifying antibody ligands for polyclonal antisera (1995) (30)
- Surface Expression of Transglutaminase 2 by Dendritic Cells and its Potential Role for Uptake and Presentation of Gluten Peptides to T Cells (2007) (30)
- Phagocytic dendritic cells from myelomas activate tumor-specific T cells at a single cell level. (2001) (30)
- Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrow (2015) (29)
- Unlocking bat immunology: establishment of Pteropus alecto bone marrow-derived dendritic cells and macrophages (2016) (28)
- Deletion of idiotype (Id)-specific T cells in multiple myeloma. (2000) (27)
- Tracking early autoimmune disease by bioluminescent imaging of NF-kappaB activation reveals pathology in multiple organ systems. (2009) (27)
- Tumors Escape CD4+ T-cell-Mediated Immunosurveillance by Impairing the Ability of Infiltrating Macrophages to Indirectly Present Tumor Antigens. (2015) (27)
- The cellular mechanism by which complementary Id+ and anti‐Id antibodies communicate: T cells integrated into idiotypic regulation (2010) (27)
- CD4+ T cells kill Id+ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo (2004) (27)
- Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myeloma. (1997) (27)
- Expanding the Versatility of Phage Display I: Efficient Display of Peptide-Tags on Protein VII of the Filamentous Phage (2011) (26)
- Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines. (2010) (26)
- Review: To What Extent are T Cells Tolerant to Immunoglobulin Variable Regions? (2009) (26)
- Thymic skewing of the CD4/CD8 ratio maps with the T-cell receptor alpha-chain locus. (1998) (26)
- Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor (2016) (26)
- Periplasmic expression of soluble single chain T cell receptors is rescued by the chaperone FkpA (2010) (26)
- Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice (2016) (26)
- Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research. (2006) (26)
- Recognition of λ1 and λ2 murine light chains by carrierspecific isologous T helper cells; effect of L‐H chain assembly (1983) (25)
- Eosinophils and Megakaryocytes Support the Early Growth of Murine MOPC315 Myeloma Cells in Their Bone Marrow Niches (2014) (25)
- Non-Invasive Imaging Provides Spatiotemporal Information on Disease Progression and Response to Therapy in a Murine Model of Multiple Myeloma (2012) (24)
- A role for IL-34 in osteolytic disease of multiple myeloma. (2019) (23)
- Recombinant antibodies as carrier proteins for sub-unit vaccines: influence of mode of fusion on protein production and T-cell activation. (2000) (22)
- Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells (2012) (22)
- A rearranged λ2 light gene chain retards but does not exclude x and λ1 expression (1991) (22)
- Expression level of a transgenic λ2 chain results in isotype exclusion and commitment to B1 cells (1998) (21)
- Antibody‐mediated delivery of antigen to chemokine receptors on antigen‐presenting cells results in enhanced CD4+ T cell responses (2003) (21)
- Generation of Antibody-Producing Hybridomas Following One Single Immunization with a Targeted DNA Vaccine (2012) (21)
- Chaperone-assisted thermostability engineering of a soluble T cell receptor using phage display (2013) (21)
- Idiotype-specific CD4+ T cells eradicate disseminated myeloma (2016) (20)
- Idiotype‐Specific, Major Histocompatibility Complex Restricted T Cells are of both Th1 and Th2 Type (1991) (20)
- Expanding the tools for identifying mononuclear phagocyte subsets in swine: Reagents to porcine CD11c and XCR1. (2016) (20)
- Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules (2019) (20)
- Indirect CD4+ T‐cell‐mediated elimination of MHC IINEG tumor cells is spatially restricted and fails to prevent escape of antigen‐negative cells (2014) (18)
- Molecular profiling of tumor-specific TH1 cells activated in vivo (2013) (18)
- A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza (2017) (18)
- Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells (2005) (18)
- Functional phage display of two murine α/β T-cell receptors is strongly dependent on fusion format, mode and periplasmic folding assistance (2007) (18)
- DeltaPhage—a novel helper phage for high-valence pIX phagemid display (2012) (18)
- T Cells from Multiple Sclerosis Patients Recognize Multiple Epitopes on Self‐IgG (2007) (17)
- T cells with two Tcrbeta chains and reactivity to both MHC/idiotypic peptide and superantigen. (1996) (17)
- Synthetic peptides and beta-chain gene rearrangements reveal a diversified T cell repertoire for a lambda light chain third hypervariable region. (1986) (17)
- The Magnitude and IgG Subclass of Antibodies Elicited by Targeted DNA Vaccines Are Influenced by Specificity for APC Surface Molecules (2018) (17)
- CD4+ T-cell killing of multiple myeloma cells is mediated by resident bone marrow macrophages. (2020) (16)
- Naive Idiotope-Specific B and T Cells Collaborate Efficiently in the Absence of Dendritic Cells (2014) (16)
- Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site (2019) (16)
- Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules (2015) (16)
- Coupling of HIV-1 Antigen to the Selective Autophagy Receptor SQSTM1/p62 Promotes T-Cell-Mediated Immunity (2016) (15)
- Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma. (2013) (15)
- Tumor-specific CD4+ T cells eradicate myeloma cells genetically deficient in MHC class II display (2016) (15)
- Heterodimeric Barnase-Barstar Vaccine Molecules: Influence of One versus Two Targeting Units Specific for Antigen Presenting Cells (2012) (15)
- Targeting Antigens to Different Receptors on Conventional Type 1 Dendritic Cells Impacts the Immune Response (2020) (15)
- Restricted alpha/beta receptor gene usage of idiotype-specific major histocompatibility complex-restricted T cells: selection for CDR3-related sequences. (1992) (14)
- Cyclized Oligopeptide Targeting LRP5/6-DKK1 Interaction Reduces the Growth of Tumor Burden in a Multiple Myeloma Mouse Model (2017) (14)
- Preferential Positive Selection of T Lymphocytes which Express Two Different TCRα Chains, an Endogenous and a Transgenic (1995) (14)
- Increased Generation of HIV-1 gp120-Reactive CD8+ T Cells by a DNA Vaccine Construct Encoding the Chemokine CCL3 (2014) (14)
- Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells (2016) (13)
- Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models (2004) (13)
- The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin (2017) (13)
- Polarity of CD4+ T cells towards the antigen presenting cell is regulated by the Lck adapter TSAd (2018) (13)
- In Silico Prediction Analysis of Idiotope-Driven T–B Cell Collaboration in Multiple Sclerosis (2017) (13)
- H‐2‐Linked Ir Genes Have a Striking Influence on the Immunogenicity of Idiotopes of Myeloma Protein 315 for T Helper Cells (1985) (12)
- Expression of SH2D2A in T-cells is regulated both at the transcriptional and translational level. (2008) (12)
- Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza (2018) (12)
- Targeted idiotype‐fusion DNA vaccines for human multiple myeloma: preclinical testing (2011) (12)
- Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza. (2019) (12)
- Human XCR 1 + Dendritic Cells Derived In Vitro from CD 34 + Progenitors Closely Resemble Blood Dendritic Cells , Including Their Adjuvant Responsiveness , Contrary to Monocyte-Derived Dendritic Cells (2014) (12)
- DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8+ T Cell Responses, Enabling Faster Resolution of Influenza Disease (2016) (12)
- Idiotype-Specific Th Cells Support Oligoclonal Expansion of Anti-dsDNA B Cells in Mice with Lupus (2014) (12)
- Human receptors of innate immunity (CD14, TLR2) are promising targets for novel recombinant immunoglobulin-based vaccine candidates. (2007) (11)
- PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors (2020) (11)
- Troybodies and pepbodies. (2001) (11)
- Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice (2017) (11)
- Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation (2014) (11)
- A DNA Vaccine That Encodes an Antigen-Presenting Cell-Specific Heterodimeric Protein Protects against Cancer and Influenza (2020) (10)
- Systemic Lupus Erythematosus: Molecular Mimicry between Anti-dsDNA CDR3 Idiotype, Microbial and Self Peptides—As Antigens for Th Cells (2015) (10)
- DNA Vaccines: MHC II-Targeted Vaccine Protein Produced by Transfected Muscle Fibres Induces a Local Inflammatory Cell Infiltrate in Mice (2014) (10)
- Is Secretion of Tumour‐specific Antigen Important for Cancer Eradication by CD4+ T Cells? – Implications for Cancer Immunotherapy by Adoptive T Cell Transfer (2011) (9)
- Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza. (2015) (9)
- B lymphoma cells process and present their endogenous IG: implications for network theory. (1988) (9)
- Processing of an Antigenic Sequence from IgG Constant Domains for Presentation by MHC Class II1 (2008) (8)
- SH2D2A Modulates T Cell Mediated Protection to a B Cell Derived Tumor in Transgenic Mice (2012) (8)
- Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes (2005) (8)
- ARHGAP45 controls naïve T‐ and B‐cell entry into lymph nodes and T‐cell progenitor thymus seeding (2021) (7)
- 'Troy-bodies': antibodies as vector proteins for T cell epitopes. (2001) (7)
- Mechanical loading prevents bone destruction and exerts anti-tumor effects in the MOPC315.BM.Luc model of myeloma bone disease. (2020) (7)
- B cell receptor ligation induces display of V-region peptides on MHC class II molecules to T cells (2019) (7)
- V lambda-light chain genes reconstitute immune responses to defined carbohydrate antigens or haptens by utilizing different VH genes. (1996) (7)
- Stabilizing mutations increase secretion of functional soluble TCR-Ig fusion proteins (2010) (7)
- Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma (2015) (7)
- A mouse model for immunotherapy of myeloma. (2002) (7)
- A VH4-34+ myeloma protein with weak autoreactivity. (2007) (7)
- Human Cysteine Cathepsins Degrade Immunoglobulin G In Vitro in a Predictable Manner (2019) (6)
- Dominant suppressive effect of the silent E αb allele on an in vivo T helper cell response under E βd E αd region‐linked immune response gene control (1985) (6)
- Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice (2014) (6)
- Determinant‐specific regulation of T helper cell responses to murine lambda light chains by both H‐2 and non‐H‐2 genes (1984) (6)
- Functional phage display of two murine alpha/beta T-cell receptors is strongly dependent on fusion format, mode and periplasmic folding assistance. (2007) (6)
- Induction of central T cell tolerance: Recombinant antibodies deliver peptides for deletion of antigen‐specific CD4+8+ thymocytes (2005) (6)
- Neoantigen Synthetic Peptide Vaccine for Multiple Myeloma Elicits T Cell Immunity in a Pre-Clinical Model (2017) (6)
- The idiotype connection: linking infection and multiple sclerosis. (2010) (6)
- Specificity of antibody and helper T-cell responses to the isologous myeloma protein W3129 and its subunits. (1984) (6)
- Endocytosis Deficient Murine Xcl1-Fusion Vaccine Enhances Protective Antibody Responses in Mice (2019) (6)
- Limitations of bystander killing in Th1/M1 immune responses against a secreted tumor antigen (2014) (6)
- Recombinant antibodies for delivery of antigen: a single loop between beta-strands in the constant region can accommodate long, complex and tandem T cell epitopes. (2008) (6)
- B‐cell tolerance to the B‐cell receptor variable regions (2013) (5)
- Monoclonal antibodies specific for variable and constant domains of murine lambda chains. (1989) (5)
- Fixation of Tissue Sections for TUNEL Combined with Staining for Thymic Epithelial Cell Marker (1997) (4)
- Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief (2021) (4)
- Integration of T helper and BCR signals governs enhanced plasma cell differentiation of memory B cells by regulation of CD45 phosphatase activity (2021) (4)
- “Troy-bodies”: Recombinant Antibodies that Target T Cell Epitopes to Antigen Presenting Cells (2001) (4)
- Anti‐Class II Antibodies, but not Cytotoxic T‐Lymphocyte Antigen 4–Immunoglobulin Hybrid Molecules, Prevent Rejection of Major Histocompatibility Complex Class II‐Negative Myeloma in T‐Cell Receptor‐Transgenic Mice (2004) (3)
- No recombinations between Tcra-V and Tcra-C gene segments in 669 backcross mice (2004) (3)
- CD40/APC-specific antibodies with three T-cell epitopes loaded in the constant domains induce CD4+ T-cell responses. (2012) (3)
- Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens (2022) (2)
- Transient overexpression of CD4 enhances allelic exclusion of T-cell receptor (TCR) alpha chains and promotes positive selection of class II-restricted TCR-transgenic thymocytes. (1998) (2)
- A Public T cell Receptor Recognized by a Monoclonal Antibody Specific for the D‐J Junction of the β‐chain (2013) (2)
- Multiple Myeloma-Derived Extracellular Vesicles Modulate the Bone Marrow Immune Microenvironment (2022) (2)
- Prevention of Bone Destruction by Mechanical Loading Is Not Enhanced by the Bruton’s Tyrosine Kinase Inhibitor CC-292 in Myeloma Bone Disease (2021) (2)
- Targeting of HA to chemokine receptors induces strong and cross-reactive T cell responses after DNA vaccination in pigs. (2019) (2)
- The Matrigel Cytokine Assay (2011) (2)
- Endocytic pathways regulate Toll-like receptor 4 signaling and mediate crosstalk between innate and adaptive immunity (2006) (2)
- Autocrine ampli fi cation of immature myeloid cells by IL-6 in multiple myeloma-in fi ltrated bone marrow (2019) (2)
- Recognition of lambda 1 and lambda 2 murine light chains by carrier-specific isologous T helper cells; effect of L-H chain assembly. (1983) (2)
- Phosphorylation-mediated EZH 2 inactivation promotes drug resistance in multiple myeloma (2018) (2)
- [DNA--the future in vaccine technology?]. (2006) (2)
- Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses. (2022) (2)
- Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin (2020) (2)
- An Early Myeloma Bone Disease Model in Skeletally Mature Mice as a Platform for Biomaterial Characterization of the Extracellular Matrix (2020) (2)
- responses, enabling Faster resolution of influenza Disease (2016) (1)
- Author Correction: Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site (2020) (1)
- T‐Cell Receptor Alpha Haplotype influences Vα Epitope Expression on both Cortisone‐Resistant Thymocytes and Lymph Node T Cells (1993) (1)
- Clonal deletion ofspecific thymocytes byan immunoglobulin idiotype (1993) (1)
- A Tcra congenic mouse: Vα epitope expression is influenced by both Tcra haplotypes and background genes (2004) (1)
- CSF1R-Inhibition and Reduction of Macrophages Delays Multiple Myeloma Growth in a Non-T-Cell-Dependent Manner (2014) (1)
- APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces Plasmodium falciparum-Specific Neutralizing Antibodies and T Cell Responses (2021) (1)
- EMD originates from hyaluronan-induced homophilic interactions of CD44 variant-expressing MM cells under shear stress (2022) (1)
- PD-1 Blockade Reinvigorates Bone Marrow CD8 þ T Cells from Patients with Multiple Myeloma in the Presence of TGF b Inhibitors (2020) (1)
- Thymic selection of immunoglobulin idiotype specific T-cells. (1994) (1)
- Lymphoma invisibility-vaccination-attack? (2011) (1)
- Antibody Responses to λ1J558 and λ2315 Light Chains (1984) (1)
- Targeting Xcr1 on Dendritic Cells Rapidly Induce Th1-Associated Immune Responses That Contribute to Protection Against Influenza Infection (2022) (1)
- P19-39. Vaccibodies: a novel vaccine strategy for HIV that target viral antigens to APC (2009) (1)
- Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice (2014) (1)
- Heterodimers MHC class II soluble functional stabilized by disulfide bonds (2011) (0)
- CD40/APC-specific antibodies with three T-cell epitopes loaded in the constant domains induce CD4 1 T-cell responses (2012) (0)
- Migratory Dendritic Cells of the CD8 Mouse Lymphoid-Tissue Resident and Cutting Edge: Expression of XCR1 Defines (2011) (0)
- Intranasal delivery of a cDC1 targeted influenza vaccine with poly(I:C) enhances T cell responses and protects against influenza infection (2021) (0)
- Author index (1987) (0)
- Monocyte-Derived Dendritic Cells Their Adjuvant Responsiveness , Contrary to Resemble Blood Dendritic Cells , Including Progenitors Closely + Vitro from CD 34 Dendritic Cells Derived In + Human XCR (2014) (0)
- United States Patent Bogen (2017) (0)
- Author Correction: Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site (2020) (0)
- single cell level Phagocytic dendritic cells from myelomas activate tumor-specific T cells at a (2013) (0)
- Cytokine profile of successful cancer immunosurveillance mediated by tumor-specific CD4+ T cells (2009) (0)
- Tumor immunity and immunosurveillance (PP-093) (2010) (0)
- Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site (2019) (0)
- Escape of myeloma cells from CD4 T-cell-driven immunoprotection (P2015) (2013) (0)
- Target T Cells and Could Be an Efficient Vaccine +Internalizes Antigen for Presentation to CD4 Adaptive Immunity: Toll-Like Receptor 2 Cutting Edge: Link Between Innate and (2003) (0)
- The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin (2017) (0)
- Abstract B37: Mechanisms of CD4 T-cell tumor immunity in a preclinical model of multiple myeloma (2020) (0)
- D. Plan for Second Five-year Period, including Exit Strategy, Cir, 179573 A. Research Plan (0)
- VSIG4-expressing tumor-associated macrophages impair anti-tumor immunity. (2022) (0)
- CD4+ T cells indirectly kill tumor cells via induction of cytotoxic macrophages (2020) (0)
- MHC-restricted Ig V region-driven T-B lymphocyte collaboration: B cell Receptor ligation facilitates switch to IgG production (2005) (0)
- APC-targeting increases immunogenicity of DNA vaccines, and can modulate the type of immune responses that are induced (2014) (0)
- in Mice with Lupus Cells Oligoclonal Expansion of Anti-dsDNA B Idiotype-Specific Th Cells Support (2014) (0)
- 103 Modulation of Human Basophilic Responses by a Fibroleukin-Allergen Fusion Protein (2012) (0)
- InfluenzaAntibody-Mediated Protection against MHC Class II Molecules Rapidly Induces DNA Vaccine that Targets Hemagglutinin to (2013) (0)
- Targeting Notch and Hedgehog Embryonic Signaling Pathways Has Potent Anti-Tumor Activity in Myeloma and Is Effective in Myeloma Bone Disease. (2012) (0)
- Naïve anti-Id B cells and Id-specific CD4+ T cells collaborate efficiently to non infectious antigens in the absence of dendritic cells. (122.12) (2012) (0)
- Abstract 2518: Effective vaccination against melanoma in an animal study: Combination of laser-assisted dermal skin delivery and cross-presenting XCR1+ dermal DCs targeting (2015) (0)
- Mechanisms of CD4 T Cell Tumor Immunity in a Preclinical Model of Multiple Myeloma (2018) (0)
- Activation and deletion of T cells in tumors containing primed antigen presenting cells (1997) (0)
- Polarity of CD4+ T cells towards the antigen presenting cell is regulated by the Lck adapter TSAd (2018) (0)
- CD4+ T cell-mediated protection against tumors: no bystander killing (P2114) (2013) (0)
- T Cell Recognition of the Dominant I-Ak–Restricted Hen Egg Lysozyme Epitope (2001) (0)
- Neoantigen-specific CD4+ T cells induce protective, tumor-specific CD8+ T cells in a mouse model of multiple myeloma. (2019) (0)
- CS14-2. A cancer-protective role of inflammation (2011) (0)
- Equivalent Dendritic Cells Uncovered in Healthy and Simian Immunodeficiency Virus–Infected Rhesus Macaques (2014) (0)
- Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza (2023) (0)
- Abstract A54: Laser-assisted intradermal delivery of Xcl1-specific fusion vaccines induces potent antitumor response (2015) (0)
- Antibody-mediated delivery of T-cell epitopes to antigen-presenting cells induce strong CD4 and CD8 T-cell responses. (2021) (0)
- Welcome to the 40th Scandinavian Society for Immunology meeting at Geilo, Norway (2011) (0)
- Class II IgG Constant Domains for Presentation by Processing of an Antigenic Sequence from and (2008) (0)
- Targeted Remodeling of the Tumor Microenvironment Via Mechanical Stimulation Defines a Novel Therapeutic Strategy in Myeloma Bone Disease (2017) (0)
- Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza. (2023) (0)
- Antibody responses to lambda 1J558 and lambda 2315 light chains. Specificity and genetic regulation. (1984) (0)
- T Helper Cell Recognition of Two Types of Mouse Lambda Light Chains (1983) (0)
- Idiotypes and T Cell Selection (2020) (0)
- Tumor immunity and immunosurveillance, session 2 (WS-093b) Chairpersons: Takashi Nishimura, Jean-Pierre Abastado (2010) (0)
- Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules (2019) (0)
This paper list is powered by the following services:
Other Resources About Bjarne Bogen
What Schools Are Affiliated With Bjarne Bogen?
Bjarne Bogen is affiliated with the following schools:
